Fielding Johnson III, M.D.
NPI 1346336237ActiveIndividual· Internal Medicine, Pulmonary Disease· East Hartford, CT
Internal Medicine, Pulmonary Disease (M.D.) in East Hartford, Connecticut, licensed in CT, with an NPI issued in October 2006. Their prescriptions cost Medicare Part D more than their services did: $1,164,756 for 8,869 claims, against $24,473 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 37 companies reporting payments in 2025, $3,964 in all, mostly food and beverage.
Overview
| NPI | 1346336237 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Oct 5, 2006 |
| Last updated in NPPES | Jun 17, 2021 |
| Certified by provider | Jun 17, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 038695 | CT |
| Internal Medicine, Critical Care Medicine | 207RC0200X | 038695 | CT |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (CT); Practitioner - Internal Medicine (MA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 89 |
|---|---|
| Services billed | 343 across 26 procedure codes |
| Paid by Medicare | $24,473 |
Part D prescriptions in 2024
| Prescriptions (claims) | 8,869 · 11,962 30-day fills |
|---|---|
| Patients | 272 |
| Total drug cost | $1,164,756 |
| Generic share | 77% of claims |
Education and affiliations
| Graduation year | 1986 |
|---|---|
| Medicare specialty | Internal Medicine |
Industry payments (Open Payments)
- 2025$3,964 · 108 payments from 37 companies
- 2024$5,126 · 153 payments from 36 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $499.14 | 12 |
| Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) | $435.12 | 5 |
| Glaxosmithkline, LLC. | $400.96 | 10 |
| Abbvie Inc. | $350.25 | 14 |
| Neurocrine Biosciences, Inc. | $280.48 | 3 |
What the 2025 payments were for
- Food and Beverage$3,964 · 108 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other pulmonologists in East Hartford
- 1669476016